NCT01612065View on ClinicalTrials.gov

Optimum Misoprostol Dose Prior to Office Hysteroscopy

PHASE3CompletedINTERVENTIONAL
Enrollment

132

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

March 31, 2013

Study Completion Date

April 30, 2013

Conditions
InfertilityAbnormal Uterine and Vaginal Bleeding, UnspecifiedRecurrent Abortion
Interventions
DRUG

Misoprostol

200 ug

DRUG

Misoprostol

Misoprostol vaginally, 400 ug

Trial Locations (1)

12211

Kasr alainy hospital, faculty of medicine , Cairo university, Cairo

All Listed Sponsors
lead

Cairo University

OTHER

NCT01612065 - Optimum Misoprostol Dose Prior to Office Hysteroscopy | Biotech Hunter | Biotech Hunter